Alnylam Announces Second Annual Advocacy for Impact Grants Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures tepid as Middle East tensions keep investors wary
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- Snowflake soars 20% on earnings beat and raised guidance
Alnylam Pharmaceuticals (ALNY) PT Raised to $159 at Cantor Fitzgerald
November 21, 2019 6:54 AM ESTCantor Fitzgerald analyst Alethia Young raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $159.00 (from $150.00) while maintaining a Overweight rating.
... More